Dimethandrolone dodecylcarbonate

Dimethandrolone dodecylcarbonate (DDC) is a synthetic androgen and anabolic steroid (AAS) and a derivative of nandrolone. It is specifically a C17α alkylated, C7α carboxylated, C11β methylated, and C21 dodecylcarbonate ester of dimethandrolone (7α,11β-dimethyl-19-nortestosterone).

History

Dimethandrolone dodecylcarbonate was first described in a 2002 patent application by the University of Southern California. It was developed for potential use as a long-acting injectable male contraceptive and for the treatment of conditions such as hypogonadism, muscle wasting and osteoporosis.

Pharmacology

As an AAS, DDC is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and moderate androgenic effects, which give it a favorable anabolic-to-androgenic ratio.

Side Effects

Potential side effects of DDC include virilization in women, gynecomastia in men, and cardiovascular and hepatic concerns. As with all AAS, it has potential for abuse and dependence.

See Also

• List of androgen esters
• List of androgen prodrugs
• List of androgens/anabolic steroids

References

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian